Details of issuance or disposal
Monthly exercise status of the 20th Series Stock Acquisition Rights (with an exercise price adjustment clause) issued through a third-party allotment
Shares issued during the month: 1,162,000 shares (new shares: 1,162,000; treasury shares transferred: 0)
The lower thin line represents the existing number of shares to which these shares will be added.
Exercise ratio under the exercise restrictions: 3.5% (1,162,000 shares / 33,543,560 shares)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of the 20th Series Stock Acquisition Rights (with an exercise price adjustment clause) issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares issued during the month: 1,162,000 shares (new shares: 1,162,000; treasury shares transferred: 0) |
| Intended allottee | EVO FUND (issued on 14 October 2025) |
| Dilution Rate | Exercise ratio under the exercise restrictions: 3.5% (1,162,000 shares / 33,543,560 shares) |
| Total number of issued shares | 43,981,560 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | Exercise price during the target month: ¥54–¥57. Details of the adjustment clause and floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 141,000 rights; exercised during the target month: 11,620 rights; unexercised at the end of the preceding month: 32,120 rights; unexercised at month-end: 20,500 rights |
| Most recent equity financing | 14 October 2025: Issuance of the 20th Series Stock Acquisition Rights (with an exercise price adjustment clause) and the 1st Series Unsecured Bonds (private placement) (detailed amount: Not disclosed) |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.This is a report on the monthly exercise status, and the company has provided no explanation of the reasons for the exercises.